Omeros Corp. (OMER)
12.20
+0.12
(+0.99%)
USD |
NASDAQ |
Jan 22, 15:35
Omeros Free Cash Flow: -105.32M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Edgewise Therapeutics, Inc. | -132.64M |
| GeoVax Labs, Inc. | -24.29M |
| Vistagen Therapeutics, Inc. | -53.96M |
| Daré Bioscience, Inc. | -17.15M |
| Spero Therapeutics, Inc. | -27.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.47M |
| Cash from Investing (Quarterly) | -6.861M |
| Cash from Financing (Quarterly) | 25.82M |
| Free Cash Flow Per Share (Quarterly) | -0.2789 |
| Free Cash Flow to Equity (Quarterly) | 0.088M |
| Free Cash Flow to Firm (Quarterly) | -18.48M |
| Free Cash Flow Yield | -14.33% |